Vascugen Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Later Stage VC
- Investors
-
4
Vascugen General Information
Description
Developer of regenerative medicine therapies designed to address degenerative vascular and ischemic disease conditions directly. The company's therapies utilize induced pluripotent stem cells and focus on advancing a pipeline of cell therapeutics to restore function to tissues where blood flow has been restricted, enabling physicians and medical researchers to develop therapeutic payloads in cardiovascular, solid tumor, and other indications.
Contact Information
Website
www.vascugen.comCorporate Office
- 5602 Research Park Boulevard
- Suite 213
- Madison, WI 53719
- United States
Corporate Office
- 5602 Research Park Boulevard
- Suite 213
- Madison, WI 53719
- United States
Vascugen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 07-Sep-2023 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 24-Aug-2020 | Completed | Pre-Clinical Trials | |||
| 1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
Vascugen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed A-2 | ||||||||
| Seed A-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Vascugen Comparisons
Industry
Financing
Details
Vascugen Competitors (7)
One of Vascugen’s 7 competitors is BlueRock Therapeutics, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BlueRock Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Century Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Sana Biotechnology | Formerly VC-backed | Seattle, WA | ||||
| Celularity | Formerly VC-backed | Florham Park, NJ | ||||
| Fate Therapeutics | Formerly VC-backed | San Diego, CA |
Vascugen Patents
Vascugen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023069480-A1 | Hypoimmune vasculogenic cells | Inactive | 20-Oct-2021 | ||
| US-20200281986-A1 | Engineering mesodermal precursor cell compositions for the treatment or prophylaxis of perfusion disorders | Inactive | 07-Sep-2018 |
Vascugen Signals
Vascugen Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cook Medical | PE-Backed Company | Minority | ||
| Angel (individual) | Minority | |||
| IU Ventures | Corporate Venture Capital | Minority | ||
| Indiana University | Limited Partner |
Vascugen FAQs
-
When was Vascugen founded?
Vascugen was founded in 2017.
-
Where is Vascugen headquartered?
Vascugen is headquartered in Madison, WI.
-
What is the size of Vascugen?
Vascugen has 4 total employees.
-
What industry is Vascugen in?
Vascugen’s primary industry is Drug Discovery.
-
Is Vascugen a private or public company?
Vascugen is a Private company.
-
What is Vascugen’s current revenue?
The current revenue for Vascugen is .
-
How much funding has Vascugen raised over time?
Vascugen has raised $10.8M.
-
Who are Vascugen’s investors?
Cook Medical, , IU Ventures, and Indiana University have invested in Vascugen.
-
Who are Vascugen’s competitors?
BlueRock Therapeutics, Century Therapeutics, Sana Biotechnology, Celularity, and Fate Therapeutics are some of the 7 competitors of Vascugen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process